Control of proteinuria with increased doses of agalsidase alfa in a patient with Fabry disease with atypical genotype

Other users also viewed these articles

Multiple parapelvic cysts in Fabry disease María A. Azancot, Josefa Vila, Carmen Domínguez, Xavier Serres, Eugenia Espinel

10.1016/j.nefroe.2016.06.004

Is just enzyme replacement therapy enough for Fabry disease treatment? Have we missed a trick? Hakan Ozer, Ismail Baloglu, Ali Topkac, Yasin Ozturk, Fethi Yonet, Furkan Daglı, İbrahim Kilinc, Kultigin Turkmen

10.1016/j.nefroe.2023.05.002

Fabry nephropathy. Role of nephrologist and clinical variables associated with the diagnosis Sebastián Jaurretche, Norberto Antongiovanni, Fernando Perretta

10.1016/j.nefroe.2018.10.009